Autism Spectrum Disorder Trial, Recruiting NCT05396352 Sponsor: American University Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05396352
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

All participants must meet these criteria:

  • Adults aged 18 to 35 years old
  • Able to give written, informed consent to participate
  • Scores at or above 85 on a standard cognitive function test called the NIH Toolbox (age-adjusted)
  • A native English speaker
  • Right-handed
  • Not currently pregnant
  • Able to attend all required study sessions
  • Passes safety screening for MRI and brain stimulation procedures (for example, no metal in the body, no implanted devices, no history of seizures, and no severe discomfort in enclosed spaces)
  • Lives in or near Washington, DC, as the study takes place at American University and Georgetown University, and no travel or accommodation funding is available

People joining as adults with autism must also meet one of these criteria:

  • Has a prior diagnosis of autism spectrum disorder (ASD) confirmed through research-reliable methods, OR
  • Meets the current diagnostic criteria for ASD, confirmed through a structured research assessment

Who may not be able to join:

For neurotypical (non-autistic) adults:

  • People outside the 18 to 35 age range
  • People who score below 85 on the NIH Toolbox cognitive function test
  • People with safety concerns related to MRI or brain stimulation, such as metal in the body, a pacemaker or other implanted device, a history of seizures, or claustrophobia
  • People with a current or past neurological condition, neurodevelopmental condition, or brain injury
  • People currently taking or with a history of taking psychiatric or mood-related medications
  • People who are pregnant

For adults with autism:

  • People outside the 18 to 35 age range
  • People who require a legally authorised representative to consent on their behalf
  • People who score below 85 on the NIH Toolbox cognitive function test
  • People with safety concerns related to MRI or brain stimulation, such as metal in the body, a pacemaker or other implanted device, a history of seizures, or claustrophobia
  • People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Kathleen Gunthert, Ph.D., American University

Phone: 202-476-4799

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
American University
Registry
ClinicalTrials.gov
Start date
1 January 2022
Est. completion
31 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reading the Mind in the Eyes Test Adult Version; Cyberball social ball-playing task; Flexible Item Selection Test; Functional MRI data

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov